Follow the (株)アイロムグループ share price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares are listed on JP JP, under the oversight of EDINET (Japan FSA). The latest transaction was disclosed on 24 March 2025 (Holding update). Among the most active insiders: Mizuho Securities Co., Ltd.. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
(株)アイロムグループ is a Japanese company specializing in clinical research services and drug development. It primarily operates in the clinical trial and related services market.